1. Home
  2. ESI vs NUVL Comparison

ESI vs NUVL Comparison

Compare ESI & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESI
  • NUVL
  • Stock Information
  • Founded
  • ESI 1922
  • NUVL 2017
  • Country
  • ESI United States
  • NUVL United States
  • Employees
  • ESI N/A
  • NUVL N/A
  • Industry
  • ESI Major Chemicals
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESI Industrials
  • NUVL Health Care
  • Exchange
  • ESI Nasdaq
  • NUVL Nasdaq
  • Market Cap
  • ESI 6.3B
  • NUVL 5.6B
  • IPO Year
  • ESI N/A
  • NUVL 2021
  • Fundamental
  • Price
  • ESI $22.93
  • NUVL $73.05
  • Analyst Decision
  • ESI Buy
  • NUVL Strong Buy
  • Analyst Count
  • ESI 8
  • NUVL 10
  • Target Price
  • ESI $30.50
  • NUVL $113.10
  • AVG Volume (30 Days)
  • ESI 5.4M
  • NUVL 583.7K
  • Earning Date
  • ESI 04-28-2025
  • NUVL 05-08-2025
  • Dividend Yield
  • ESI 1.40%
  • NUVL N/A
  • EPS Growth
  • ESI 105.98
  • NUVL N/A
  • EPS
  • ESI 1.01
  • NUVL N/A
  • Revenue
  • ESI $2,456,900,000.00
  • NUVL N/A
  • Revenue This Year
  • ESI N/A
  • NUVL N/A
  • Revenue Next Year
  • ESI $5.75
  • NUVL N/A
  • P/E Ratio
  • ESI $22.92
  • NUVL N/A
  • Revenue Growth
  • ESI 5.30
  • NUVL N/A
  • 52 Week Low
  • ESI $22.71
  • NUVL $61.80
  • 52 Week High
  • ESI $29.78
  • NUVL $113.51
  • Technical
  • Relative Strength Index (RSI)
  • ESI 30.15
  • NUVL 41.46
  • Support Level
  • ESI $24.86
  • NUVL $71.95
  • Resistance Level
  • ESI $26.77
  • NUVL $77.93
  • Average True Range (ATR)
  • ESI 0.85
  • NUVL 3.11
  • MACD
  • ESI -0.27
  • NUVL 0.11
  • Stochastic Oscillator
  • ESI 5.18
  • NUVL 58.12

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company has two segments which are Electronics and Industrial & Specialty. The Industrial & Specialty segment which generates majority of the revenue, includes chemical systems that protect and decorate metal and plastic surfaces; consumable chemicals that enable printing image transfer on flexible packaging materials; and chemistries used in water-based hydraulic control fluids in offshore energy production. Electronics segment researches, formulates and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: